Qiu C, Liu K, Zhang S, Gao S, Chen W, Li D, & Huang Y. (2020). Bisdemethoxycurcumin Inhibits Hepatocellular Carcinoma Proliferation Through Akt Inactivation via CYLD-Mediated Deubiquitination. Dove Medical Press.
Chicago Style (17th ed.) CitationQiu C, Liu K, Zhang S, Gao S, Chen W, Li D, and Huang Y. Bisdemethoxycurcumin Inhibits Hepatocellular Carcinoma Proliferation Through Akt Inactivation via CYLD-Mediated Deubiquitination. Dove Medical Press, 2020.
MLA (9th ed.) CitationQiu C, et al. Bisdemethoxycurcumin Inhibits Hepatocellular Carcinoma Proliferation Through Akt Inactivation via CYLD-Mediated Deubiquitination. Dove Medical Press, 2020.
Warning: These citations may not always be 100% accurate.